Depot-medroxyprogesterone acetate does not reduce the prophylactic efficacy of emtricitabine and tenofovir disoproxil fumarate in macaques

Concerns that the injectable contraceptive depot-medroxyprogesterone acetate (DMPA) may increase the risk of HIV acquisition in women led to questions on whether DMPA could reduce efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention. We used a macaque model to investigate the impact of pro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Radzio, Jessica, Hanley, Krisztina, Mitchell, James, Ellis, Shanon, Deyounks, Frank, Jenkins, Leecresia, Heneine, Walid, Garcia-Lerma, J. Gerardo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2014
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4213266/
https://ncbi.nlm.nih.gov/pubmed/25202923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000340
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak